March 22, 2018 6:17 AM ET


Company Overview of eXegenics Inc.

Company Overview

As of March 27, 2007, eXegenics, Inc. was acquired by Acuity Pharmaceuticals, Inc. and Froptix Corporation in a reverse merger transaction. eXegenics, Inc., a clinical-stage biopharmaceutical company, focuses on the development of therapies for the treatment and prevention of ophthalmic disease. The company, based on its RNA Interference technology, develops a product candidate called bevasiranib, which is a small interfering RNA (siRNA) therapeutic targeting vascular endothelial growth factor. It develops bevasiranib as an intravitreal injection for the treatment of wet age-related macular degeneration (Wet AMD), and other related ocular conditions. The company is also developing treatments...

4400 Biscayne Boulevard

Suite 900

Miami, FL 33137

United States





Key Executives for eXegenics Inc.

eXegenics Inc. does not have any Key Executives recorded.

Similar Private Companies By Industry

Company Name Region
20n Labs, Inc. United States
23andMe, Inc. United States
2C Tech Corporation, Inc. United States
3-V Biosciences, Inc. United States
3Bar Biologics Inc. United States

Recent Private Companies Transactions

No transactions available in the past 12 months.

The information and data displayed in this profile are created and managed by S&P Global Market Intelligence, a division of S&P Global. does not create or control the content. For inquiries, please contact S&P Global Market Intelligence directly by clicking here.

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup

Most Searched Private Companies

Company Name Geographic Region
Lawyers Committee for Civil Rights Under Law United States
The Advertising Council, Inc. United States
Tax Management Inc United States
John F. Kennedy Center For The Performing Arts United States
NYC2012, Inc. United States

Sponsored Financial Commentaries

Sponsored Links

Request Profile Update

Only a company representative may request an update for the company profile. Documentation will be required.

To contact eXegenics Inc., please visit --. Company data is provided by S&P Global Market Intelligence. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at